查尔斯河出售制造与发现业务，兑现战略转型承诺。
Charles River sells manufacturing and discovery businesses to fulfill promised pivot
生命科学资讯
生物技术与制药领域的最新动态
查尔斯河实验室出售其CDMO及欧洲发现业务部门。
Charles River sells its CDMO and European discovery businesses
查尔斯河公司强调，随着关税不确定性消退，需求增长显著。
Charles River highlights increase in demand as tariff uncertainties fade
赛默飞世尔与查尔斯河裁员；药明康德与Vertex签订合同
Thermo Fisher, Charles River workforce cuts; WuXi signs contract with Vertex
查尔斯河将关闭细胞疗法CDMO基地，裁员20名员工。
Charles River to close cell therapy CDMO site, lay off 20 staffers
查尔斯河实验室新任CEO表示，减少动物实验是生命科学研发领域的"渐进式变革而非革命性突破"。
Reducing animal testing 'an evolution and not a revolution' for life sci R&D, Charles River's incoming CEO says
查尔斯河实验室斥资5.1亿美元收购灵长类动物供应商。
Charles River inks $510M deal to bring primate supply in-house
查尔斯河长期领导者吉姆·福斯特即将退休，首席运营官将接掌大权。
Longtime Charles River leader Jim Foster to retire, with COO set to take the helm
查尔斯河实验室CEO吉姆·福斯特将退休；三星生物收购葛兰素史克工厂
Charles River CEO Jim Foster to retire; Samsung Bio buys a GSK factory